A 63-Year-Old Woman With Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
EP. 1: Impressions of a Woman With EGFR+ Metastatic NSCLC
Watch
EP. 2: Current Molecular Testing Strategies for EGFR+ NSCLC
EP. 3: EGFR-TKIs in First-Line EGFR+ Metastatic NSCLC
EP. 4: EGFR-VEGF Inhibition for First-Line EGFR+ mNSCLC Treatment
EP. 5: EGFR+ mNSCLC: Monitoring Treatment Response and Next Steps
EP. 6: Future Directions in EGFR+ NSCLC
